NIAID releases statement on early zidovudine use.
D015704:CD4 Antigens / Q000032:analysis; D015658:HIV Infections / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D015215:Zidovudine / Q000009:adverse effects / Q000627:therapeutic use*
D015704:CD4 Antigens; D015215:Zidovudine